Pfizer, Inc. Settles Wrongful Death Lawsuit Involving Neurontin
The Wall Street Journal reports Pfizer Inc., maker of the anti-seizure drug Neurontin, has agreed to pay a widow an undisclosed amount following her husband’s death in 2002. The woman claimed her husband’s suicide was a result of his use of Neurontin.
Her lawsuit alleged Pfizer was aware the drug was associated with the risk of suicide, but the company failed to properly warn the public and that Pfizer promoted the use of the drug for the effects of paralysis (as in her husband’s case) even though it was not approved by U.S. regulators.
Pfizer said that it had strong defenses to the plaintiff’s claims but decided to settle the case for less than the remaining defense costs in the case.
Pfizer has had years of legal problems resulting from their marketing of Neurontin. In 2004, Pfizer pleaded guilty to a criminal charge and agreed to pay $430 million to settle investigations by the government over its promotion of Neurontin. Just a few weeks ago, a federal jury concluded Pfizer violated other laws and awarded damages of $47 million – which will be automatically tripled under the law. Pfizer plans to appeal this judgment.
The New York offices of Scott C. Gottlieb have vast experience dealing with wrongful death cases. If you feel that you or a loved one has suffered due to wrongful death, call our firm at 800-825-5529 or visit our web site. There is no case-review cost.